Phoenix Bio

論文一覧

論文一覧

論文一覧

Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression

    Win, N. N. Kanda, T. Nakamoto, S. Moriyama, M. Jiang, X. Suganami, A. Tamura, Y. Okamoto, H. Shirasawa, H.

    Int J Med Sci. 2018 Jul 30;15(11):1153-1159.

    新規ready-to-use ヒト肝細胞三次元培養システム「PXB-able」の有用性の検討

      赤平有希、山崎ちひろ、石田雄二、立野知世、城村友子

      BIO-INDUSTRY 2018;35(3):27-37

      Contribution of chimeric mice with a humanized liver to the evaluation of pharmacology, toxicity, and pharmacokinetics in drug discovery and development

        Sanoh, S. Ohta, S.

        Nihon Yakurigaku Zasshi. 2018;151(5):213-220

        Use of hepatocytes isolated from a liver-humanized mouse for studies on the metabolism of drugs: application to the metabolism of fentanyl and acetylfentanyl

          Kanamori, T. Togawa-Iwata, Y. Segawa, H. Yamamuro, T. Kuwayama, K. Tsujikawa, K. Inoue, H.

          Forensic Toxicol. 2018;36(2):467-475.

          Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure

            Teraoka, Y. Uchida, T. Imamura, M. Hiraga, N. Osawa, M. Kan, H. Saito, Y. Tsuge, M. Abe-Chayama, H. Hayes, C. N. Makokha, G. N. Aikata, H. Miki, D. Ochi, H. Ishida, Y. Tateno, C. Chayama, K.

            J Gen Virol. 2018 Jun 19. doi: 10.1099/jgv.0.001091.

            Generation of the Adenovirus Vector-Mediated CRISPR/Cpf1 System and the Application for Primary Human Hepatocytes Prepared from Humanized Mice with Chimeric Liver

              Tsukamoto, T. Sakai, E. Iizuka, S. Taracena-Gandara, M. Sakurai, F. Mizuguchi, H.

              Biol Pharm Bull. 2018;41(7):1089-1095. doi: 10.1248/bpb.b18-00222.

              Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers

                Furuta, M. Tanaka, H. Shiraishi, Y. Unida, T. mamura, M. Fujimoto, A. Fujita, M. Sasaki-Oku, A. Maejima, K. Nakano, K. Kawakami, Y. Arihiro, K. Aikata, H. Ueno, M. Hayami, S. Ariizumi, S. I. Yamamoto, M. Gotoh, K. Ohdan, H. Yamaue, H. Miyano, S. Chayama, K. Nakagawa, H.

                Oncotarget. 2018 May 18;9(38):25075-25088.

                The whole transcriptome effects of the PPARalpha agonist fenofibrate on livers of hepatocyte humanized mice

                  de la Rosa Rodriguez, M. A. Sugahara, G. Hooiveld, Gjej Ishida, Y. Tateno, C. Kersten, S.

                  BMC Genomics. 2018 Jun 7;19(1):443. doi: 10.1186/s12864-018-4834-3.

                  Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction

                    Tsukamoto, Y. Ikeda, S. Uwai, K. Taguchi, R. Chayama, K. Sakaguchi, T. Narita, R. Yao, W. L. Takeuchi, F. Otakaki, Y. Watashi, K. Wakita, T. Kato, H. Fujita, T.

                    PLoS One. 2018 May 21;13(5):e0197664.

                    Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery

                      Naritomi, Y. Sanoh, S. Ohta, S.

                      Drug Metab Pharmacokinet. 2017 Nov 9. pii: S1347-4367(17)30150-7. doi: 10.1016/j.dmpk.2017.11.001.

                      Identifying and Characterizing Interplay between Hepatitis B Virus X Protein and Smc5/6

                        Livingston, C. M. Ramakrishnan, D. Strubin, M. Fletcher, S. P. Beran, R. K.

                        Viruses. 2017 Apr 3;9(4). pii: E69. doi: 10.3390/v9040069.

                        Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver

                          Ohshita, H. Tateno, C.

                          Methods Mol Biol. 2017;1506:91-100. (Book of Hepatocyte Transplantation)

                          Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice

                            Teraoka, Y. Uchida, T. Imamura, M. Osawa, M. Tsuge, M. Abe-Chayama, H. Hayes, C. N. Makokha, G. N. Aikata, H. Miki, D. Ochi, H. Ishida, Y. Tateno, C. Chayama, K.

                            Biochem Biophys Res Commun. 2018 Jun 2;500(2):152-157.

                            Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions

                              Takaoka, N. Sanoh, S. Okuda, K. Kotake, Y. Sugahara, G. Yanagi, A. Ishida, Y. Tateno, C. Tayama, Y. Sugihara, K. Kitamura, S. Kurosaki, M. Terao, M. Garattini, E. Ohta, S.

                              Biochem Pharmacol. 2018 Apr 17;154:28-38.

                              FXR Activation by Obeticholic Acid or Non-Steroidal Agonists Induces a Human-Like Lipoprotein Cholesterol Change in Mice with Humanized Chimeric Liver

                                Papazyan, R. Liu, X. Liu, J. Dong, B. Plummer, E. M. Lewis, R. D., 2nd Roth, J. D. Young, M. A.

                                J Lipid Res. 2018 Mar 20. pii: jlr.M081935. doi: 10.1194/jlr.M081935.

                                Acute HBV infection in humanized chimeric mice has multiphasic viral kinetics

                                  Ishida, Y. Chung, T. L. Imamura, M. Hiraga, N. Sen, S. Yokomichi, H. Tateno, C. Canini, L. Perelson, A. S. Uprichard, S. L. Dahari, H. Chayama, K.

                                  Hepatology. 2018 Mar 23. doi: 10.1002/hep.29891.

                                  Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection

                                    Rolt, A. Le, D. Hu, Z. Wang, A. Q. Shah, P. Singleton, M. Hughes, E. Dulcey, A. E.He, S. Imamura, M. Uchida, T. Chayama, K. Xu, X. Marugan, J. J. Liang, T. J.

                                    J Infect Dis. 2018 Jan 24. pii: 4823490. doi: 10.1093/infdis/jiy039.

                                    A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage

                                      Reddy, B. U. Mullick, R. Kumar, A. Sharma, G. Bag, P. Roy, C. L. Sudha, G. Tandon, H. Dave, P. Shukla, A. Srinivasan, P. Nandhitha, M.Srinivasan, N. Das, S.

                                      Antiviral Res. 2017 Dec 7;150:47-59.

                                      Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B viruses

                                        Nishitsuji, H. Harada, K. Ujino, S. Zhang, J. Kohara, M. Sugiyama, M. Mizokami, M. Shimotohno, K.

                                        Cancer Sci. 2018 Jan;109(1):241-249.

                                        Hepatitis C replication inhibitors that target the viral NS4B protein

                                          Miller, J. F. Chong, P. Y. Shotwell, J. B. Catalano, J. G. Tai, V. W. Fang, J. Banka, A. L. Roberts, C. D. Youngman, M. Zhang, H. Xiong, Z. Mathis, A. Pouliot, J. J. Hamatake, R. K. Price, D. J. Seal, J. W., 3rd Stroup, L. L. Creech, K. L. Carballo, L. H. Todd, D. Spaltenstein, A. Furst, S. Hong, Z. Peat, A. J.

                                          J Med Chem. 2014 Mar 13;57(5):2107-20